Dietary Supplements for Health

Palo Alto (17 mi)

Age: 18+

Sex: Any

Travel: May be covered

Time Reimbursement: Varies

Trial Phase: Phase 4

Waitlist Available

Sponsor: OvationLab

Prior Safety Data

Trial Summary

What is the purpose of this trial?The primary purpose of this study is to compare the safety and effectiveness of commercially available dietary supplements believed to increase coenzyme Q10 (CoQ10) concentrations. An 8-week, randomized, placebo-controlled clinical trial will be conducted comparing the effectiveness of four commercially available dietary supplements on increasing CoQ10 concentrations and self-reported health outcomes.

Eligibility Criteria

This trial is for individuals interested in improving their health and wellness. Participants should be willing to take dietary supplements or a placebo for 8 weeks. There are no specific inclusion criteria provided, but typically participants must meet certain health standards.

Inclusion Criteria

I am 40 years old or older.

Exclusion Criteria

I have been taking a statin medication in the last 6 months.

I am currently taking bisphosphonates every day.

I am unable to give consent by myself.

I use acid reflux medication daily.

I have a chronic condition that makes me unsuitable for this study.

Treatment Details

The study tests the safety and effectiveness of four dietary supplements: Ubiquinol with geranylgeraniol, Ubiquinone alone, Ubiquinol alone, Geranylgeraniol alone, against a placebo. The goal is to see which one increases CoQ10 levels best over an 8-week period.

5Treatment groups

Experimental Treatment

Placebo Group

Group I: Ubiquinone (NOW CoQ10 200mg)Experimental Treatment1 Intervention

Group II: Ubiquinol + geranylgeraniol combination (Designs for Health - CoQnol™ 200)Experimental Treatment1 Intervention

Group III: Ubiquinol (Jarrow Formulas QH-absorb® 200 mg)Experimental Treatment1 Intervention

Group IV: Geranylgeraniol (Annatto-GG™ 300)Experimental Treatment1 Intervention

Group V: PlaceboPlacebo Group1 Intervention